Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Durogesic D-TRANS in Cancer Pain
NCT01060124Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in cancer pain, sponsored by Janssen Pharmaceutical. Started Apr 2007; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01060124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060124.